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Paris polyphylla var. yunnanensis (Fr.) Hand-Mazz. 
is a perennial medicinal plant from the Euthyra Franch 
group in the Trilliaceae family, mostly distributed in the 
southwest of China. The rhizome of Paris polyphylla is 
used in traditional Chinese medicine as a haemostatic 
and antimicrobial agent [1, 2]. Recently, studies of the 
aqueous, ethanolic and methanolic extracts of Paris 
polyphylla showed their anticancer activity on several 
types of cancer cell lines. More extensive phytochemi-
cal and pharmacological studies further identified 
steroid saponins as the main antitumor active com-
ponents [1, 3–6]. Paris saponins are a group of plant 
glycosides consisting of a steroid aglycone, to which 
one or more sugar chains are attached. They exhibit cell 
membrane–permeabilizing properties and, thus, have 
been investigated for their therapeutic potential [7]. 
Steroid saponins from Paris polyphylla are classified in 
two main groups: diosgenin (Dio) glycosides and pen-
nogenin glycosides. Furthermore, D-glycopyranoside, 
L-rhamnopyranoside and L-arabinofuranoside are 
the main glycosides linked in the structure of steroid 
saponins [8]. However, the relationship between the 
anticancer activity and structure of the steroid saponins 
of Paris polyphylla had not yet been reported.
Preliminary screening of Paris polyphylla steroid 
saponins anti-proliferative activity revealed inhibitory 
effect of these compounds on cell growth of LA795 
lung adenocarcinoma cell line. Eight known steroid 
saponins were isolated from the rhizome of Paris poly-
phylla [9, 10]. In our experiments, the anticancer activi-
ty of these steroid saponins of was investigated. Their 
cytotoxicity was evaluated by MTT assay, and apopto-
sis was studied by AnnexinV-FITC/PI staining. We also 
studied the antitumour effects of Diosgenin-3-α-L-
arabinofuranosyl(1→4)-[α-L-rhamnopyranosyl(1→2)]-
β-D-glycopyranoside (compound 1), the main steroid 
saponin from Paris Polyphylla, and diosgenin (Dio), 
the aglycone of compound 1, on inbred strains of 
laboratory mice (T739) that carried LA795 metastatic 
lung cancer. The relationships between anticancer 
activity and structure of Paris polyphylla saponins were 
discussed in this paper.
MATERIALS AND METHODS
Plant material and extracts preparation. The 
herb Paris polyphylla var. yunnanensis had been 
collected from Yunnan Province in the southwestern 
part of China, and identified by Dr. Gao. Voucher 
specimen (No.057902) was deposited in School of 
Pharmaceutical Science and Technology of Tianjin 
University. The rhizome of Paris polyphylla was dried 
at room temperature, and powdered, and extracted by 
organic solvents. After using column chromatography 
on Sephadex LH-20, PTLC and PHPLC, eight steroid 
saponins, titled compound 1 to 8, were obtained 
(Fig. 1) [9, 10]. The purity of compound 4 is > 75%, 
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and the purity of other seven compounds is > 90%. 
Diosgenin (the purity > 99.9%) was purchased from 
Sigma-Aldrich Chemie GmbH.
R’O
O
O
R
R R'
Compound 1 H -α-L-arabinofuranosyl(1→4)-[α-L-rhamnopyranosyl(1→2)]-
β-D-glycopyranoside
Compound 2 OH -α-L-arabinofuranosyl(1→4)-[α-L-rhamnopyranosyl(1→2)]-
β-D-glycopyranoside
Compound 3 H -α-L-rhamnopyranosyl(1→4)-[α-L-rhamnopyranosyl(1→2)]-
β-D-glycopyranoside
Compound 4 OH -α-L-rhamnopyranosyl(1→4)-[α-L-rhamnopyranosyl(1→2)]-
β-D-glycopyranoside
Compound 5 H -α-L-arabinofuranosyl(1→4)-β-D-glycopyranoside
Compound 6 OH -α-L-arabinofuranosyl(1→4)-β-D-glycopyranoside
Compound 7 H -α-L-rhamnopyranosyl(1→4)-[α-L-rhamnopyranosyl(1→4)]-
[α-L-rhamnopyranosyl(1→2)]-β-D-glycopyranoside
Compound 8 OH
Diosgenin H H
Fig. 1. Structure of diosgenin and compound 1~8 [9, 10]
Cell line and culture. The mice lung adenocarcino-
ma cell line (LA795) was purchased from Peking Union 
Medicial College (Beijing, China). The LA795 cells were 
maintained in RPMI-1640 medium supplemented with 
10% heat-inactivated fetal bovine serum (FBS), penicil-
lin (100 U/mL) and streptomycin (100 μg/mL) at 37 °C in 
5% CO2. Cells were passaged every 3–4 days.
In vitro assay for cytotoxicity (MTT assay). 
LA795 cells (3 × 104 cells/mL) were plated on 96-well 
plates (200 μL of medium per well). After 24 h, cells 
were synchronized by adding serum-free media. After 
another 24 h, the cells were treated with various concen-
trations of DMSO solutions of studied compounds (con-
centration of DMSO < 0.1%). Each solution was added 
to eight wells. In another 24 h, 100 μL of 0.5 mg/mL MTT 
medium was added to each well for another 4 h. The 
supernatant fluid was then removed, 100 μL per well of 
DMSO was added, and samples were shaken for 15 min. 
Absorbance at 570 nm was measured with an enzyme-
linked immunosorbent assay plate reader. This experi-
ment was carried out in triplicate. Growth inhibition (GI) 
was calculated according to the formula: GI = 1 – (A570 
of treated cells / A570 of control cells). IC50 values were 
calculated using a linear regression of dose-dependent 
curves plotted from at least six points.
Annexin V-FITC/PI staining for apoptosis 
evalua tion. Apoptosis was quantified using flow 
cytometry to measure the levels of detectable 
phosphatidylserine on the outer membrane of apop-
totic cells. LA795 cells were seeded on 6-well plates 
(3 × 104 cells/mL), and incubated with the compounds 
in 0.02% DMSO solutions. The concentration of each 
compound was equal to one third from respective IC50 
value. After 24 h, cells were harvested by centrifuga-
tion, washed twice with PBS at 4 °C, and re-suspended 
in diluted binding buffer from the Annexin V-FITC kit 
at a concentration of 1 × 106 cells/mL. 100 μL of this 
suspension was added to a 5 mL Flow Cytometry (FC) 
tube. 5 μL of AnnexinV-FITC and 10 μL of 20 mg/mL 
propidium iodide (PI) were further added to the tube, 
followed by 15 min of incubation in the darkness. 
400 mL of PBS were then added. Quantitative analysis 
of apoptotic cells level was performed using a Flow 
Cytometer (Coulter Epics Altra, Beckman Coulter Inc., 
USA). The procedure was carried out three times.
In vivo tumor growth inhibition. T739 inbred mice, 
both male and female, weighting 18.0 ± 2.0 g, were 
obtained from the Laboratory Animal Breeding and 
Research Center, Cancer Hospital, Academy of Medical 
Science (Beijing, China). The animals were kept under 
pathogen-free conditions, and fed with chow and sterile 
water ad lib. This animal study was approved by the 
Institutional Animal Care and Use Committee of China, 
and Institutional guidelines for animal welfare. LA795 
cells (1 × 107/mL) were injected subcutaneously into the 
right armpits of the mice. Tumors grew to a volume of 
0.5 to 1.0 cm3. After sacrificing the mice, the tumor was 
excised, cut into small pieces (volume 0.5–1.0 mm3) 
and dipped in 0.9% Sodium Chloride at 4 °C. After filt-
ration and deliquation the pieces dispersed into cells. 
Those tumor cells were then injected into recipient mice 
(2 × 106/mL, 0.2 mL for each mouse). Thus, T739 mice 
(n = 40) bearing LA795 lung adenocarcinoma were 
obtained. Five days after injection of LA795 cells, forty 
T739 mice bearing LA795 lung adenocarcinoma were 
randomly divided into four groups (n = 10 per group): 
1) control group (0.1 ml/10 g distilled water, p. o.), 2) cy-
clophosphamide (CPH) treated group (20 mg/kg, i. p.), 
3) compound 1-treated group (100 mg/kg, p. o.), and 
4) diosgenin-treated group (200 mg/kg., p. o.). Drugs 
were administered daily for 14 days, once a day.
At the first and the last days of the experiment, the 
body weight of each mouse was measured. The tumor 
volume was estimated every other day, on the basis of 
two-dimensional tumor measurements performed with 
a micrometer, and resorting to the formula suggested by 
Kato et al. (1994): Tumor vol. (mm3) = 0.5A × B2, where 
A is the longest diameter and B the shortest diameter 
of the tumor. The mice were sacrificed at the day 14, 
and autopsies were performed. Major organs such 
as lung, liver, kidneys, spleen, and tumor mass were 
then dissected and their weights were measured. The 
spleen index was calculated using the formula: spleen 
index = weight of spleen (mg) / body weight (g). The 
tumor inhibitory rate was calculated using the formula: 
tumor inhibitory rate (%) = 100% × (mean tumor weight 
in control mice minus mean tumor weight in treated 
mice) / mean tumor weight in control mice.
Histological examination. Dissected organs 
(lung, liver, kidneys) were fixed in 10% paraformal-
dehyde (pH 7.5) and then processed for paraffin 
embedding according to the standard histological 
procedures. 4 μm-thick sections were prepared and 
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stained with HE stain. Histopathological examination 
was completed using Olympus microscopy.
TUNEL assay. Apoptotic cells in the tumor sec-
tions were visualized by the terminal deoxyncleotidyl 
transferase mediated d-UTP nick and labeling (TUNEL) 
technique according to the manufacturer’s instruction 
(Chemicon International, Inc, USA). Tissue sections 
were treated with 10 μg/mL proteinase K for 10 min at 
room temperature. The slides were immersed in a 2% 
H2O2 solution to block endogeneous peroxidase activi-
ty. TdT was used to catalyze the addition of biotin-con-
jugated d-UTP to the 3’-OH ends of DNA fragments. 
The incorporated biotin was detected by streptavidin 
conjugated to horseradish peroxidase. The staining 
was then performed using 3, 3’-diaminobenzidine 
tetrahydrochloride (DAB) as the chromagen and H2O2 
as the substrate. Tissue sections were counterstained 
with hematoxylin and then mounted. Cells with deep-
brown stained nuclei were counted as positive.
Statistical analysis. SPSS for Windows (SPSS Inc.) 
was used to analyze the data and plot curves. Data was 
expressed as the mean ± standard deviation (SD). The 
statistical significance of differences observed between 
each treatment group and the control was determined 
by the Student’s t-test (two-tailed). Differences were 
considered statistically significant if p < 0.05.
RESULTS 
Inhibition of LA795 cells growth in vitro. Nine 
compounds (compounds 1–8 and Diosgenin) were 
screened using MTT assay. These compounds showed 
remarkable cytotoxicity against LA795 cell in a dose-
dependent manner (Fig. 2). Their median inhibitory 
concentration (IC50) are listed in Table 1.
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Fig. 2. Inhibitory effect of compound 1~8 and diosgenin on 
LA795 cell growth. LA795 cells were treated with compounds 1~8 
or diosgenin at different concentrations for 24 h, and the growth 
inhibition was determined using the MTT assay
Table 1. IC50 of the compounds (x
— ± S, n = 3)
Compound IC50 (μmol/L) 
Compound 1 1.85 ± 0.11
Compound 2 5.14 ± 0.29
Compound 3 3.06 ± 0.33
Compound 4 2.26 ± 0.47
Compound 5 39.00 ± 3.63
Compound 6 319.53 ± 24.77
Compound 7 1.35 ± 0.19
Compound 8 2.71 ± 0.26 
Diosgenin 149.75 ± 10.43
Annexin V-FITC assay of LA795 cells apoptosis. 
Many chemical compounds can inhibit the growth of tumor 
cells, but not all of them can trigger apoptosis [11]. To 
determine whether apoptosis was induced by the com-
pounds mentioned above, we performed flow cytometric 
analysis with Annexin V-FITC conjugated to propidium 
iodide (PI). Annexin V-FITC-positive, PI-negative (Annexin 
V-FITC (+) PI (-)) cells were considered to be in an early 
apoptotic stage, while Annexin V-FITC-positive, PI-positive 
(Annexin V-FITC (+) PI (+)) cells were considered to be 
late apoptotic or necrotic. Apoptosis of LA795 cells was 
induced by compounds added at the concentration equal 
to one third from their IC50 values, although at different 
degree. The rates of apoptosis induced by Paris polyphylla 
compounds were significantly higher than apoptotic rate 
in the control group (p < 0.01) (Table 2).
Table 2. Flow cytometry analysis of LA795 cells after incubation with drugs 
for 24 h (x— ± S, n = 3)
Compound Dosage (μmol·L-1) Annexin (+) PI (-) (%) Annexin (+) PI (+) (%)
Control — 1.1 ± 0.3 4.6 ± 0.7
Compound 1 0.62 12.9 ± 0.5* 36.3 ± 2.6*
Compound 2 1.71 5.4 ± 0.6* 20.0 ± 1.0*
Compound 3 1.02 6.8 ± 0.2* 32.3 ± 3.0*
Compound 4 0.75 8.6 ± 1.0* 34.9 ± 3.1*
Compound 5 13.00 3.7 ± 0.1* 13.5 ± 1.7*
Compound 6 106.51 1.3 ± 0.1 18.2 ± 0.4*
Compound 7 0.45 13.7 ± 0.3* 41.1 ± 2.4*
Compound 8 0.90 10.3 ± 0.9* 39.6 ± 1.9*
Diosgenin 49.92 3.4 ± 0.3* 11.8 ± 1.7*
Notes: Annexin (+) PI (-) (%): the percentage of cells in an early apoptotic stage; 
Annexin (+) PI (+) (%): the percentage of cells in a late apoptotic or necrotic 
stage. *p < 0.01 scores of drug-administered group vs control group.
Anti-tumor effects of the compounds in vivo. 
Although any reduction of the tumor volume was not 
observed between the drug treatment groups, tumor 
masses increased much slowly than in the control group 
during the period of drug administration (Fig. 3). Even-
tual tumor weight in all treated groups was obviously 
lower than in the control group (p < 0.01) (Table 3). That 
indicated CPH, compound 1 and Dio didn’t make the 
solid tumors disappear, but slow down their growth.
6 9 12 15 18
0
1000
2000
3000
4000
5000
6000  Control
 CPH
 Compound 1
 Dio
Days after inoculation
Tu
m
ou
r v
ol
um
e 
(m
m
3 )
*
*
Fig. 3. Effect of drug treatment on tumor volume. CPH: Cy-
clophosphamide; Dio: Diosgenin. *p < 0.01 scores of drug-
administered group vs control group.
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Table 3. Inhibitory effects of drug treatment on LA795 transplanted 
tumors in T739 mice
Group Dosage (mg/kg/d)
Tumour volume 
(mm3)
Tumour 
weight (g)
Inhibition of growth 
of tumour (%)
Control — 5462.5 ± 105.5 6.3 ± 0.6 
CPH 20 2912.7 ± 252.9* 2.8 ± 0.4* 56.09
Compound 1 100 4234.0 ± 486.4 4.4 ± 0.5* 29.44
Dio 200 4005.1 ± 762.4 4.2 ± 0.5* 33.94
Notes: CPH: Cyclophosphamide; Dio: Diosgenin. *p < 0.01 scores of drug-
administered group vs control group.
Our original purpose of including the cyclophos-
phamide (CPH) group was to compare the anticancer 
activity of compound 1 with the CPH group, because 
CPH is generally used for treatment of various types 
of cancers. It is a clinically approved anticancer agent 
that works by slowing or stopping cell growth. Its use 
is becoming more common in anticancer experimental 
research, and the dosage (20 mg/kg) of the CPH treat-
ed group was referred to previous reports [12, 13].
The solid tumor in the control group grew well and 
the average tumor weight reached 6.3 g. Meanwhile, 
CPH exhibited significant anti-tumor activity. In the 
CPH group (20 mg/kg, i. p.), the average tumor weight 
was only 2.8 g and the inhibitory ratio was 56.09%. 
Compound 1 and Diosgenin also exerted a remarkable 
inhibitory effect on tumor growth. In the compound 
1-treated group (100 mg/kg, p. o.) and the Diosgenin-
treated group (200 mg/kg, p. o.), the tumor weights 
were significantly reduced (p < 0.01). The inhibitory 
ratio of tumor growth reached 29.44% and 33.94%, 
respectively (see Table 3).
The body weight of mice in the treatment groups ap-
peared to be slightly decreased in comparison with the 
control group, but these results were not statistically-
valid (p > 0.05) (Table 4). Spleen index in all three treat-
ment groups (CPH, compound 1 and Diosgenin) was 
reduced compared with the control group, especially 
the spleen index of mice treated with compound 1.
Table 4. Effects of drug treatment on body weight and spleen index of 
T739 mice bearing LA795 lung adenocarcinoma
Group Dosage (mg/kg/d)
Body weight (g) 
Spleen indexBefore the 
treatment
After the 
treatment
Control — 23.7 ± 1.1 23.9 ± 1.0 6.8 ± 1.1
CPH 20 24.4 ± 1.3 23.6 ± 1.3 5.3 ± 0.4 
Compound 1 100 24.0 ± 0.8 23.5 ± 1.1 4.5 ± 0.7*
Dio 200 25.0 ± 1.1 24.7 ± 1.1 6.0 ± 0.8
Notes: CPH: Cyclophosphamide; Dio: Diosgenin. *p < 0.05 scores of drug-
administered group vs control group.
Effects of compounds on lung, liver, kidneys, 
and tumor mass in mice. In order to investigate the 
toxicity of the treated compounds, lung, liver and 
kidney sections were prepared and stained by HE. 
Lesions of various degree were found in the lungs and 
livers of treatment groups. The kidney microstructure 
was normal. For the compound 1 group, lungs were 
seriously damaged with a large area of hemorrhagic 
infarction (Fig. 4, a). For other groups (CPH and 
Diosgenin), there were congestion and inflamma-
tory infiltration of lungs. Also, the liver lesions in mice 
treated with compound 1 were the most severe among 
all three treatment groups. As shown on Fig. 4, b and 
4, c, the normal structure of the hepatic lobules was 
destroyed, and hydropic degeneration, inflammatory 
infiltration and fatty degeneration were observed. For 
other treatment groups, slight hydropic degeneration 
and inflammatory infiltration was found.
a
b
c
Fig. 4. Pathological changes in lungs and livers of T739 mice 
bearing LA795 lung adenocarcinoma upon compound 1 treat-
ment. a, lung tissue, showing hemorrhagic infarction, 100 ×. 
b, liver tissue, showing inflammatory infiltration, 400 ×. c, liver 
tissue, showing fatty degeneration, 400 ×
TUNEL assay. TUNEL assay of tumor sections 
was performed to examine the ability of compound 1 
to induce cell apoptosis. The apoptosis index is pre-
sented on Fig. 5. Compared with the control group, 
the number of apoptosis cells increased significantly 
for all three treatment groups. The apoptosis index of 
the compound 1 group was 6-fold higher than that of 
the control group, and was almost on the same level 
as shown for the CPH group.
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Fig. 5. The number of apoptotic cells in tumor sections were detected 
by TUNEL assay. Apoptotic cells in tumors increased significantly 
in drug-treated groups. CPH: Cyclophosphamide; Dio: Diosgenin. 
*p < 0.01 scores of drug-administered group vs control group.
DISCUSSION
Currently chemotherapy is regarded as one of the 
most efficient cancer treatment aproach. Although 
chemotherapy significantly improves symptoms and 
the quality of life of patients with lung cancer, only 
modest increase in survival rate can be achieved. 
Faced with palliative care, many cancer patients use 
alternative medicines, including herbal therapies. 
Among these therapies, traditional Chinese medicine 
is probably the best established and codified, dating 
back several thousand years. Traditionally, Chinese 
herbs are used in combinations of single herbs, or 
prescriptions — called formulas. Specific herbal ex-
tracts, and combinations, have been designed to treat 
specific diseases including cancer [14–16].
Paris polyphylla var. yunnanensis has been tradi-
tionally used for centuries. Some medical formula, 
such as Chonglou-Tang, which includes this Chinese 
herb as a main ingredient, have been used to treat 
cancer. Recent studies pointed to steroid saponins as 
the main anti-tumor components of this herb. Previous 
studies pointed that Paris polyphylla var. yunnanensis 
contained significant amounts of steroid saponins, 
including polyphyllin D, diosgeninscin, gracillin, trillin, 
methylmotogracillin, and so on [5, 6, 17–21].
In the experiments in vitro, as shown in MTT results, 
diosgenin saponins had stronger cytotoxicity than 
pennogenin saponins. These compounds had remar-
kable cytotoxicity against LA795 cell, and eight steroid 
saponins (except compound 6) had higher inhibition 
of cell growth compared with diosgenin.
Compound 7 with four glycosides had shown the 
highest rate of cell growth inhibition among other 
studied steroid saponins, while compounds 5 and 
6, containing two glycosides, exhibited the lowest 
inhibition rate both among diosgenin and penno-
genin saponins. This data indicates that the number 
of glycosides correlate with the cytotoxicity of steroid 
saponins. However, IC50 of compound 4 was lower than 
that of compound 3 and compound 8. This phenome-
non could be explained by the fact that the purity of 
compound 4 was approximately 75%, and the purity of 
other seven compounds was more than 90%.
Compared with compound 3 and compound 2, 
compound 1 and 4 showed higher cytotoxicity rate, re-
spectively. Although the number of glycosides in com-
pounds was the same, the varieties of glycosides were 
different. Besides glycopyranoside and rhamnopyra-
noside, their main difference was that compounds 1 
and compound 2 contain arabinofuranosides, and 
that compound 3 and 4 contain rhamnopyranosides. 
When there was used aglycone of diosgenin, the 
activity of rhamnopyranoside was stronger than of 
arabinofuranoside-containing compound. But when 
there was aglycone of pennogenin, the effect was op-
posite. This indicated that the variety of glycosides of 
steroid saponins also could affect cytotoxicity.
Altogether, the 3-O-glycoside moiety and spiro-
stanol structure were found to be essential for the 
proapoptotic activity with regard to anticancer struc-
tural relationship of steroid saponins. Their cytotoxic 
activities were strongly influenced by the number and 
the variety of steroid saponins.
Compound 1 was the main steroid saponin com-
ponent in Paris polyphylla, and the contents of other 
seven compounds were very few. So compound 1 and 
diosgenin (Dio), the aglycone of compound 1 were 
selected for in vivo experiment. And we hope that the 
anti-tumor activities in vivo of other compounds could 
be estimated through the results of compound 1. In 
in vivo experiment, the molar dose of compound 1 was 
set to one-quarter of diosgenin, because of the high 
toxicity of compound 1 for mice. The results showed 
that compound 1 was as effective as diosgenin with the 
4-fold molar dose in inhibition of tumor growth. This 
further indicated that glycosides of steroid saponins 
promote the anticancer activity of diosgenin. From the 
results of tissue sections HE staining, it is seen that 
compound 1 caused stronger lung and liver damage 
than diosgenin. Probably the 3-O-glycoside structure 
may contribute to the toxicity of steroid saponins.
Treatment of tumors is directed not only on inhibition 
of cell proliferation, but also on induction of apoptosis 
of tumor cells. More and more attention is paid to the 
ability of drugs to induce apoptosis in the process of 
evaluation of anti-tumor agents’ effectiveness. That 
is why we tested the ability of eight steroid saponins 
extracted from Paris polyphylla to induce apoptosis by 
means of AnnexinV-FITC/PI flow cytometry approach. 
The rates of apoptosis in the treatment groups were 
significantly higher than that in the control group, which 
was shown by AnnexinV-FITC/PI flow cytometry. Addi-
tionally, in TUNEL assay of tumor sections, the number 
of apoptotic cells in tumors treated with compound 1 
was increased too. This data suggest that one of anti-
tumor mechanisms of steroid saponins is an induction of 
tumor cell apoptosis. The main biologic activity ascribed 
to saponins is their membrane permeabilizing property. 
The main actions are considered changes in membrane 
permeability and pore formation [22–24]. In apoptotic 
death, an increase of mitochondrial membrane perme-
ability is considered to be one of the key events. A sud-
den increase in permeability of the inner mitochondrial 
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membrane, the so-called mitochondrial permeability 
transition, is a common feature of apoptosis and is me-
diated by the mitochondrial permeability transition pore 
(mtPTP) [25–27]. So the detailed mechanism of the 
eight steroid saponins extracted requires future study. 
In conclusion, steroid saponins of Paris polyphylla 
var. yunnanensis could be regarded as promising 
drugs for cancer therapy, but the mechanisms of their 
anti-cancer activity and their toxicity should be further 
addressed. In our studies, we demonstrated that the 
structure of spirostanol 3-O-glycoside and the number 
of glycosides were two main factors responsible for 
compounds’ cytotoxicity. Also, we plan to study further 
the saponins structure-function relationships, and per-
form structure modifications to design new compounds 
with strong anti-tumor activity and low toxicity.
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